Literature DB >> 10235631

Angiotensin II and aldosterone regulation.

P J Mulrow1.   

Abstract

The circulating renin-angiotensin system is a major regulator of the secretion of the adrenocortical hormone, aldosterone. This renin-angiotensin aldosterone system is important in the control of salt and water balance and blood pressure. This review describes the historical background leading to the discovery of aldosterone in the 1950s and the recognition in the 1960s that angiotensin II was involved in its control. Although angiotensin II is important in the regulation of aldosterone secretion, its action is influenced by multiple other factors, especially potassium and atrial natriuretic peptide. In addition to the circulating renin-angiotensin system, a local renin-angiotensin system is present in the zona glomerulosa cell. This local system also appears to be involved in the regulation of aldosterone production. The mechanism by which angiotensin II stimulates the adrenal zona glomerulosa cell is described in some detail. Angiotensin II interacts with the angiotensin receptor (AT1) membrane receptor that is coupled to cellular second messengers. Specific AT1 receptor antagonists are now clinically used to block angiotensin II's action on various target organs, including the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235631     DOI: 10.1016/s0167-0115(99)00004-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  14 in total

Review 1.  Central regulation of blood pressure by the mineralocorticoid receptor.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

2.  Local aldosterone synthesis in the large intestine of mouse: An ex vivo incubation study.

Authors:  Zan Pang; Hanna Launonen; Riitta Korpela; Heikki Vapaatalo
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

3.  Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

Authors:  Klaus Höcherl; Dierk Endemann; Martin C Kammerl; Horst F Grobecker; Armin Kurtz
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

4.  Prevention and Reversal of LV Remodeling with Neurohormonal Inhibitors.

Authors:  Richard D. Patten; Prem Soman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-08

5.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

6.  Localisation of renin-angiotensin system (RAS) components in breast.

Authors:  M Tahmasebi; S Barker; J R Puddefoot; G P Vinson
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

Review 7.  Local Renin-Angiotensin system in the reproductive system.

Authors:  Daniel Herr; Inga Bekes; Christine Wulff
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-18       Impact factor: 5.555

Review 8.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 9.  Renin-angiotensin system blockade for the risk of cancer and death.

Authors:  Jian Shen; Yan-Mei Huang; Min Wang; Xue-Zhi Hong; Xin-Nan Song; Xia Zou; Yan-Hong Pan; Wei Ling; Min-Hui Zhu; Xiao-Xi Zhang; Yi Sui; Hai-Lu Zhao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-07-08       Impact factor: 1.636

10.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.